Figure 2From: NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3NSC114792 selectively inhibits JAK3 kinase activity in vitro. JAK1 (A), JAK2 (B), JAK3 (C), or TYK2 (D) immunoprecipitates were used for in vitro kinase assay. Each immunoprecipitate was pre-incubated with either vehicle (DMSO) alone, NSC114792 at different concentrations or the pan-JAK kinase inhibitor AG490 (100 μmol/L) for 1 hour. Kinase reactions were subsequently performed by the addition of recombinant STAT3α protein as a substrate and 2 μmol/L ATP for 30 minutes at 30°C. The reaction products were processed for Western blotting and probed with antibodies specific for phospho-STAT3, STAT3, JAK1, JAK2, JAK3, and TYK2. Note that NSC114792 blocks JAK3 kinase activity in a dose-dependent manner but failed to inhibit the kinase activity of other JAK family members. STAT3, JAK1, JAK2, JAK3, and TYK2 serve as a loading control.Back to article page